切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2020, Vol. 16 ›› Issue (04) : 417 -422. doi: 10.3877/cma.j.issn.1673-5250.2020.04.007

所属专题: 文献

论著

子宫内膜非典型性息肉样腺肌瘤的临床分析
魏宝宝1, 刘辉1,()   
  1. 1. 四川大学华西第二医院妇产科、出生缺陷与相关妇儿疾病教育部重点实验室,成都 610041
  • 收稿日期:2019-11-09 修回日期:2020-07-13 出版日期:2020-08-01
  • 通信作者: 刘辉

Clinical analysis of atypical polypoid adenomyomas

Baobao Wei1, Hui Liu1,()   

  1. 1. Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
  • Received:2019-11-09 Revised:2020-07-13 Published:2020-08-01
  • Corresponding author: Hui Liu
  • About author:
    Corresponding author: Liu Hui, Email:
  • Supported by:
    Key Research and Development Project of Science & Technology Department of Sichuan Province(2017FZ0068)
引用本文:

魏宝宝, 刘辉. 子宫内膜非典型性息肉样腺肌瘤的临床分析[J]. 中华妇幼临床医学杂志(电子版), 2020, 16(04): 417-422.

Baobao Wei, Hui Liu. Clinical analysis of atypical polypoid adenomyomas[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2020, 16(04): 417-422.

目的

探讨子宫内膜非典型性息肉样腺肌瘤(APA)的临床特点、治疗及预后情况。

方法

选取2012年9月1日至2019年10月1日,四川大学华西第二医院收治的经术后活组织病理学检查确诊为APA的16例患者为研究对象。采用回顾性分析方法,对其临床表现,术后活组织病理学检查、辅助检查、治疗结果及预后等进行分析。本研究遵循的程序符合2013年新修订的《世界医学协会赫尔辛基宣言》要求。

结果

纳入本研究的16例APA患者的临床分析结果如下。①一般临床资料:患者发病年龄为23~59岁[(40.8±10.7)岁];15例为绝经前女性,1例为绝经后女性。②临床表现:不规则阴道流血、异常阴道流液、尿频与尿痛、盆腔包块分别为12、2、1及1例。③术前合并症:术前合并≥1种合并症,如不孕症、子宫肌瘤、子宫内膜非典型增生等为11例,其余5例无合并症。④术前经阴道彩色多普勒超声检查结果:宫腔内未见明显异常为3例;提示子宫内膜回声欠均匀、泡状液性暗区、宫腔内血流信号丰富,未见确切占位为5例;提示宫腔内占位位于宫腔中下段,宫腔内血流信号丰富为8例。⑤术后活组织病理学检查结果:提示APA伴子宫恶性肿瘤及其癌前病变为5例,其中APA伴子宫内膜灶性癌变、子宫内膜高分化腺癌、子宫内膜癌肉瘤及子宫内膜非典型增生,分别为2、1、1与1例;而APA伴子宫内膜息肉、子宫内膜复杂性增生,以及单纯性APA伴鳞状上皮化生,分别为1、1与9例。⑥治疗及随访:6例接受子宫切除术;10例接受宫腔镜下病灶切除术。其中,6例有生育要求,术后仅1例自然妊娠,但是最终流产,其余5例均未妊娠。对16例患者的随访结果显示,1例失访,对其余15例随访7~85个月(中位随访时间为42个月),尚未见APA复发。

结论

APA多发生于绝经前女性,常合并子宫内膜恶性病变,术前诊断困难,需根据术后活组织病理学检查结果确诊。对于有生育需求的APA患者,采取保留生育功能治疗后,自然妊娠率较低。

Objective

To investigate the clinical characteristics, treatment and prognosis of atypical polypoid adenomyomas (APA), so as to provide the diagnosis and treatment ideas for this disease.

Methods

From September 1, 2012 to October 1, 2019, a total of 16 patients with APA finally diagnosed by pathological examination in West China Second University Hospital, Sichuan University were selected as research subjects. The clinical data of those 16 patients were collected by retrospective analysis method, so as to summarize clinical characteristics, histopathological examination results, auxiliary examination results, treatment and prognosis of APA patients. This study met the requirements of World Medical Association Declaration of Helsinki revised in 2013.

Results

Clinical data analysis results of 16 APA patients included in the study were as follows. ①General clinical data: patients′ age ranged from 23 to 59 years old [(40.8±10.7) years old]. There were 15 cases of premenopausal women, and 1 case of postmenopausal woman. ②Clinical manifestations: 12 cases presented irregular vaginal bleeding, 2 cases presented abnormal vaginal fluid, 1 case presented frequent urination and pain, and 1 case was with pelvic mass. ③Preoperative complications: 11 cases had one or more complications, such as infertility, uterine fibroids, atypical endometrial hyperplasia, and the remaining 5 cases had no complications. ④Preoperative transvaginal color Doppler ultrasound: 3 cases had no obvious abnormalities in uterine cavity; 5 cases were not observed exact space occupation, but their endometrial echo was uneven and had the dark area of vesicular fluid, and 8 cases were observed exact space occupation and all the occupation were located in the middle and lower part of uterine cavity. Transvaginal color Doppler ultrasonography showed abundant blood flow in uterine cavity of these 13 cases. ⑤Postoperative histopathological examination: 5 cases indicated APA complicated with uterine malignant tumor or its precancerous lesion, including 2 cases of APA with endometrial focal canceration, 1 case of APA with highly endometrial differentiated adenocarcinoma, 1 case of APA with endometrial carcinosarcoma, 1 case of APA with atypical endometrial hyperplasia. Among the remaining 11 cases, 1 case was APA with endometrial polyp, 1 case was APA with endometrial complex hyperplasia, and another 9 cases were simple APA with squamous metaplasia. ⑥Treatment and follow-up: 6 cases underwent hysterectomy; the other 10 cases underwent hysteroscopic focal resection. Among the later 10 patients, 6 cases had fertility requirements, but only 1 case had natural pregnancy after surgery, and finally miscarried, the remaining 5 cases had no pregnancy. All of these patients, 1 case was lost and the remaining 15 cases was followed up for 7-85 months (median follow-up time was 42 months), no one was recurrent with APA.

Conclusions

APA mostly occurs in premenopausal women and often complicated with endometrial malignant tumor, which is difficult to be diagnosed preoperatively and depends on postoperative pathological examination. For APA patients with fertility desire, the natural pregnancy rate is low after fertility preservation treatment.

表1 本组16例APA患者的临床资料比较
患者编号(No.) 年龄(岁) 临床表现 术前合并症 术前阴道彩色多普勒超声检查结果 手术方式 术中所见宫腔占位形态 术后活组织病理学检查结果 随访时间/随访结果
1 31 月经量增多、经期延长 重度贫血、不孕症 宫腔下段稍强回声(2.9 cm×1.9 cm×2.2 cm) 宫腔镜下病灶切除术 息肉样新生物,最大直径为3.0 cm APA伴鳞状上皮化生 3年/随访期内未见APA复发
2 50 经期延长 子宫肌瘤、子宫内膜非典型增生 宫腔内未见明显异常 子宫切除术 未见明显异常 APA伴子宫内膜高分化腺癌 6年2个月/随访期内未见APA复发
3 23 月经量增多、经期延长 不孕症 宫腔中下段稍强回声(3.8 cm×2.5 cm×2.8 cm) 宫腔镜下病灶切除术 息肉样新生物,最大直径为3.0 cm APA伴鳞状上皮化生 1年/随访期内未见APA复发
4 59 异常阴道流液 子宫内膜回声不均匀 子宫切除术+诊刮术 息肉样新生物,最大直径为1.0 cm APA伴鳞状上皮化生 1年5个月/随访期内未见APA复发
5 30 经期延长 宫腔下段稍弱回声(2.9 cm×1.9 cm×2.6 cm) 宫腔镜下病灶切除术 息肉样新生物,最大直径为3.0 cm APA伴子宫内膜息肉 2年4个月/随访期内未见APA复发
6 48 尿频、尿痛 多发性子宫肌瘤 宫腔未见明显异常 子宫切除术 未见明显异常 APA伴子宫内膜癌肉瘤 失访
7 47 性生活后阴道流血 子宫肌瘤、不孕症、子宫内膜非典型增生 宫腔下段稍强回声(1.4 cm×0.7 cm×1.3 cm) 子宫切除术 菜花样新生物,最大直径为2.0 cm APA伴子宫内膜灶性癌变 2年7个月/随访期内未见APA复发
8 48 月经紊乱 子宫肌瘤、子宫内膜非典型增生 子宫内膜回声不均匀 子宫切除术 带蒂息肉样新生物,最大直径为3.0 cm APA伴子宫内膜非典型增生 2年11个月/随访期内未见APA复发
9 30 月经间期出血 子宫内膜回声不均匀 宫腔镜下病灶切除术 多发息肉样新生物,最大直径为1.0 cm APA伴子宫内膜复杂性增生 5年6个月/随访期内未见APA复发
10 48 月经量增多、经期延长 宫腔下段稍弱回声(2.1 cm×3.6 cm×2.3 cm) 宫腔镜下病灶切除术 肌瘤样新生物,最大直径为3.0 cm APA伴子宫内膜灶性癌变 6年11个月/随访期内未见APA复发
11 50 异常阴道流液 子宫肌瘤 宫腔下段稍强回声(0.4 cm×0.3 cm×0.6 cm) 宫腔镜下病灶切除术 息肉样新生物,最大直径为1.0 cm APA伴鳞状上皮化生 7个月/随访期内未见APA复发
12 29 月经量增多、经期延长 不孕症 宫腔下段稍强回声(2.5 cm×1.8 cm×2.1 cm) 宫腔镜下病灶切除术 肌瘤样新生物,最大直径为2.0 cm APA伴鳞状上皮化生 3年6个月/随访期内未见APA复发
13 27 月经量增多、经期延长 子宫肌瘤、不孕症 宫腔中段稍弱回声(1.4 cm×1.0 cm×1.3 cm) 宫腔镜下病灶切除术 肌瘤样新生物,最大直径为1.2 cm APA伴鳞状上皮化生 3年6个月/随访期内未见APA复发
14 45 月经量增多、经期延长 子宫内膜回声不均匀 宫腔镜下病灶切除术 粉红色新生物,最大直径为3.0 cm APA伴鳞状上皮化生 6年7个月/随访期内未见APA复发
15 37 月经紊乱 子宫内膜非典型增生、不孕症 子宫内膜回声不均匀 宫腔镜下病灶切除术 肌瘤样新生物,最大直径为2.0 cm APA伴鳞状上皮化生 7年1个月/随访期内未见APA复发
16 51 盆腔包块 子宫肌瘤、右侧卵巢癌 宫腔未见明显异常 子宫切除术 未见明显异常 APA伴鳞状上皮化生 6年1个月/随访期内未见APA复发
[1]
Jiang QY, Wang L, Wu RJ. A multiple perspectives on atypical polypoid adenomyoma of uterus [J]. Gynecolol Endocrinol, 2013, 29(7): 623-625. DOI: 10.3109/09513590.2013.777418.
[2]
Mazur MT. Atypical polypoid adenomyomas of the endometrium [J]. Am J Surg Pathol, 1981, 5(5): 473-482. DOI: 10.1097/00000478-198107000-00006.
[3]
Zhang HK, Chen WD. Atypical polypoid adenomyomas progressed to endometrial endometrioid adenocarcinomas [J]. Arch Gynecol Obstet, 2012, 286(3): 707-710. DOI: 10.1007/s00404-012-2355-x.
[4]
Heatley MK. Atypical polypoid adenomyoma: a systematic review of the English literature [J]. Histopathology, 2006, 48(5): 609-610. DOI: 10.1111/j.1365-2559.2005.02315.x
[5]
Chen Q, Lu WG, Lu BJ. Pregnant outcomes of atypical polypoid adenomyoma treated with progestin therapy [J]. J Obstet Gynaecol Res, 2018, 44(2): 323-330. DOI: 10.1111/jog.13527.
[6]
Nomura H, Sugiyama Y, Tanigawa T, et al. Maintenance hormonal therapy after treatment with medroxyprogesterone acetate for patients with atypical polypoid adenomyoma [J]. Jpn J Clin Oncol, 2018, 48(3): 255-258. DOI: 10.1093/jjco/hyx193.
[7]
Chiyoda T, Bao LL, Saotome K, et al. Hysteroscopic transcervical resection for atypical polypoid adenomyoma of the uterus: a valid, fertility-preserving option [J]. J Minim Invasive Gynecol, 2018, 25(1): 163-169. DOI: 10.1016/j.jmig.2017.08.659.
[8]
Buénerd A, Dargent D, Scoazec JY, et al. Carcinomatous transformation of an atypical polypoid adenomyofibroma of the uterus [J]. Ann Pathol, 2013, 23(1): 63-66. DOI: 10.1097/00000478-200302000-00024.
[9]
Mikos T, Tsolakidis D, Grimbizis GF. Clinical presentation and management of atypical polypoid adenomyomas: Systematic review of the literature [J]. Eur J Obstet Gynecol Reprod Biol, 2019, 236: 14-21. DOI: 10.1016/j.ejogrb.2019.02.027.
[10]
Němejcová K, Kenny SL, Laco J, et al. Atypical polypoid adenomyoma of the uterus: an immunohistochemical and molecular study of 21 cases [J]. Am J Surg Pathol, 2015, 39(8): 1148-1155. DOI: 10.1097/PAS.0000000000000428.
[11]
Edwards JM, Alsop S, Modesitt SC. Coexisting atypical polypoid adenomyoma and endometrioid endometrial carcinoma in a young woman with cowden syndrome: case report and implications for screening and prevention [J]. Gynecol Oncol Case Rep, 2012, 2(2): 29-31. DOI: 10.1016/j.gynor.2011.12.004.
[12]
Raffone A, Travaglino A, Saccone G, et al. Management of women with atypical polypoid adenomyoma of the uterus: a quantitative systematic review [J]. Acta Obstet Gynecol Scand, 2019, 98(7): 842-855. DOI: 10.1111/aogs.13553.
[13]
Grimbizis GF, Mikos T, Miliaras D, et al. Management of atypical polypoid adenomyomas. A case series [J]. Eur J Obstet Gynecol Reprod Biol, 2017, 215: 1-5. DOI: 10.1016/j.ejogrb.2017.05.017.
[14]
Arimoto T, Ishida M, Ebisu Y, et al. Cytomorphological features of atypical polypoid adenomyoma of the endometrium [J]. Cytopathology, 2019, 30(3): 323-325. DOI: 10.1111/cyt.12673.
[15]
Lu BJ, Yu MH, Shi HY, et al. Atypical polypoid adenomyoma of the uterus: a reappraisal of the clinicopathological and immunohistochemical features [J]. Pathol Res Pract, 2019, 215(4): 766-771. DOI: 10.1016/j.prp.2019.01.016.
[16]
Kihara A, Amano Y, Yoshimoto T, et al. Stromal p16 expression helps distinguish atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma of the uterus [J]. Am J Surg Pathol, 2019, 43(11): 1526-1535. DOI: 10.1097/PAS.0000000000001320.
[17]
Kawaguchi M, Kato H, Suzui N, et al. MR imaging findings differentiating uterine submucosal polypoid adenomyomas from endometrial polyps [J]. Br J Radiol, 2019, 92(1095): 20180430. DOI: 10.1259/bjr.20180430.
[18]
Kalmantis K, Daskalakis G, Semertzidou A, et al. The role of three-dimensional power Doppler hysterosonography (3-DPDS) in distinguishing atypical polypoid adenomyomas (APAs) from other intrauterine tumors: correlation with pathologic findings [J]. Arch Gynecol Obstet, 2017, 296(2): 391-396. DOI: 10.1007/s00404-017-4436-3.
[19]
Matsumoto T, Hiura M, Baba T, et al. Clinical management of atypical polypoid adenomyoma of the uterus. A clinicopathological review of 29 cases [J]. Gynecol Oncol, 2013, 129(1): 54-57. DOI: 10.1016/j.ygyno.2012.12.040.
[20]
McCluggage WG. A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus [J]. Mod Pathol, 2016, 29(Suppl 1): S78-S91. DOI: 10.1038/modpathol.2015.137.
[21]
Inoue K, Tsubamoto H, Hori M, et al. A case of endometrioid adenocarcinoma developing 8 years after conservative management for atypical polypoid adenomyoma [J]. Gynecol Oncol Case Rep, 2014, 8: 21-23. DOI: 10.1016/j.gynor.2014.02.001.
[1] 马中正, 杨云川, 马翔, 周迟, 丁丁, 霍俊一, 徐楠, 崔培元, 周磊. 胰腺癌双硫死亡相关的lncRNA预后模型的构建及免疫反应研究[J]. 中华普通外科学文献(电子版), 2024, 18(05): 368-376.
[2] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[3] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[4] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[7] 孙建娜, 孔令军, 任崇禧, 穆坤, 王晓蕊. 266例首诊Ⅳ期乳腺癌手术患者预后分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 502-505.
[8] 袁庆港, 刘理想, 张亮, 周世振, 高波, 丁超, 管文贤. 尿素-肌酐比值(UCR)可预测结直肠癌患者术后的长期预后[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 506-509.
[9] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[10] 肖丹, 陈辰, 查晔军, 公茂琪, 花克涵, 孙伟桐, 蒋协远. 改良松解术治疗创伤后肘关节僵硬的疗效及危险因素分析[J]. 中华老年骨科与康复电子杂志, 2024, 10(05): 257-263.
[11] 李素娟, 王文玲, 董洪敏, 李小凯, 黄思成, 王刚. 多原发与单原发大肠腺癌的预后分析[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 407-412.
[12] 孙文恺, 沈青, 杭丽, 张迎春. 纤维蛋白原与清蛋白比值、中性粒细胞与白蛋白比值、C反应蛋白与溃疡性结肠炎病情评估和预后的关系[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 426-431.
[13] 唐诗, 薛传优, 叶兴, 张鸿举, 戴瑞. 急性病毒性肝炎患者血脂、血糖、蛋白、尿酸变化特点及其与预后的关联[J]. 中华消化病与影像杂志(电子版), 2024, 14(05): 396-399.
[14] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
[15] 闫战涛, 王辉, 周梓迪, 史勇强, 陈铜兵. 胃淋巴上皮瘤样癌三级淋巴结构特征及其与预后的相关性[J]. 中华临床医师杂志(电子版), 2024, 18(05): 455-461.
阅读次数
全文


摘要